Wednesday November 25 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioPortfolio's Approved Drugs Database

Keflex

Cephalexin

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Press Releases About Keflex:

BioPortfolio Logo
MiddleBrook Pharmaceuticals to Launch Moxatag(TM) March 2009 7th January, 2009 MiddleBrook Pharmaceuticals, Inc.
The first and only FDA-approved once-daily amoxicillin will be promoted to health care professionals nationwide WESTLAKE, Texas, Jan. 7 /PRNewswire-FirstCall/ -- MiddleBrook Pharmaceuticals, Inc.
MiddleBrook to Webcast Management Presentation at the 10th Annual Rodman & Renshaw Healthcare Conference 14th October, 2008 MiddleBrook Pharmaceuticals, Inc.
GERMANTOWN, Md., Oct. 14 /PRNewswire-FirstCall/ -- MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK), a pharmaceutical company focused on developing and commercializing novel anti-infective products,
MiddleBrook Pharmaceuticals Announces Stockholder Approval and Closing of $100 Million Financing Transaction with Equity Group Investments 4th September, 2008 MiddleBrook Pharmaceuticals, Inc.
GERMANTOWN, Md., Sept. 4 /PRNewswire-FirstCall/ -- MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK), a pharmaceutical company focused on developing and commercializing novel anti-infective
MiddleBrook Pharmaceuticals Files Definitive Proxy Statement with Respect to Proposed $100 Million Investment from EGI 30th July, 2008 MiddleBrook Pharmaceuticals, Inc.
GERMANTOWN, Md., July 30 /PRNewswire-FirstCall/ -- MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK), a pharmaceutical company focused on developing and commercializing novel anti-infective
MiddleBrook Pharmaceuticals to Conduct Investor Update Conference Call on July 24, 2008 22nd July, 2008 MiddleBrook Pharmaceuticals, Inc.
GERMANTOWN, Md., July 22 /PRNewswire-FirstCall/ -- MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK), a pharmaceutical company focused on developing and commercializing novel anti-infective

This page has been viewed 51 times Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Keflex across BioPortfolio, or for Keflex Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.